Polyethylene Glycol 3350 Powder, For Solution
FDA Label NDC 55154-8091

17 label sections · Submitted to the FDA by Cardinal Health 107, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Polyethylene Glycol 3350 (NDC 55154-8091). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient (in each dose), purpose, use, warnings, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

.

TAMPER-EVIDENT: DO NOT USE IF

FOIL IS OPEN OR BROKEN

*This product is not manufactured or distributed by Bayer HealthCare LLC,

owner of the registered trademark MiraLAX®.

Distributed by MAJOR® PHARMACEUTICALS

Indianapolis, IN 46268

www.majorpharmaceuticals.com

Overbagged with 10 packets per bag, NDC 55154-8091-5

WARNING: This Unit Dose package is not child resistant and is Intended for Institutional Use Only. Keep this and all drugs out of the reach of children.

Distributed By:

Cardinal Health

Dublin, OH 43017

L56118351223

Rev. 03/22 M-17 Re-order No. 701066

Product of India 50844 REV0222D72648

Principal Display Panel

NDC 55154-8091-5

PEG3350

Polyethylene Glycol 3350

Powder for Oral Solution, Osmotic Laxative

5-Packets NET WT 0.5 OZ (17 g) EACH

100% Bag Label (D804d78d Bf7c 4ae2 A3a7 D1e7337bbeb8 00)

100% Bag Label (D804d78d Bf7c 4ae2 A3a7 D1e7337bbeb8 00)

* Please review the disclaimer below.